{
  "_id": "27211317dab83f3af2e0f801aafe9186b496cd5694f3bdb16f8265e2605c79b9",
  "feed": "market-watch",
  "title": "Merck in talks to buy cancer biotech Seagen for about $40 billion",
  "text": "<p>There is still no guarantee the companies will reach agreement on a takeover deal.</p><p>New Jersey-based Merck has a market value of around $235 billion. Acquiring Seagen would help broaden its lineup of cancer drugs, currently led by the blockbuster immunotherapy Keytruda, the company's top-selling product with $17.2 billion in sales last year.</p><p>An expanded version of this report appears on WSJ.com.</p><p>Also popular on WSJ.com:</p><p>Natalie Portman's arms are the breakout stars of 'Thor: Love and Thunder.'</p><p>Russian army turns Ukraine's largest nuclear plant into a military base.</p><p>Merck in talks to buy cancer biotech Seagen for about $40 billion</p>",
  "published": "2022-07-07T02:58:00.000Z",
  "tags": [
    {
      "id": "US58933Y1055",
      "nexusId": "10042334",
      "name": "Merck & Co., Inc.",
      "offsets": [
        {
          "start": 571,
          "end": 576
        },
        {
          "start": 100,
          "end": 105
        },
        {
          "start": 0,
          "end": 5
        }
      ]
    }
  ]
}